New Landscape of Neglected Disease Drug Development

07 Sep 2005

Report by Dr Mary Moran, of the London School of Economics.

This report highlights the dramatic change in the landscape of neglected disease drug development over the last five years but emphasizes that lack of funding may lead to the collapse of the driving force behind this new trend.